Abstract
Objective: The aim of this study was to evaluate the effects of disease burden, surgical complexity, and residual disease at interval debulking surgery (IDS) in advanced-stage ovarian cancer treated with neoadjuvant chemotherapy (NACT).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
